Imaging for early stage breast cancer

Power estimation

A marked reduction of symptoms in 15% of the patients is considered clinically relevant

A study of 150 patients with a 1:1 randomisation will have a power of approximately 80% to detect a difference in response rate of 10% versus 25% in a study without crossover

The crossover design will further improve statistical power